-
Galena Shares Up 50% On Regulatory Pathway For Thrombosis Treatment
Wednesday, December 28, 2016 - 10:56am | 327Read More...Shares of Galena Biopharma Inc (NASDAQ: GALE), a nano-cap biopharmaceutical company that focuses on hematology and oncology therapeutics for the treatment of unmet medical needs, gained more than 20 percent ahead of Wednesday's market open. Galena is currently evaluating its GALE-401 therapy for...
-
Galena Biopharma 2016 Outlook Focuses On 'High Value' Cancer Immunotherapy Pipeline
Wednesday, January 13, 2016 - 2:37pm | 263Read More...Shares of Galena Biopharma Inc (NASDAQ: GALE) were trading lower by more than 5 percent at $0.770 on Wednesday after the company detailed its 2016 strategy. Galena Biopharma noted that its 2016 strategy to advance the company's "high value" cancer immunotherapy clinical...
